MedPath

Treating Hypertension With Breath Control

Not Applicable
Conditions
Hypertension
Interventions
Behavioral: Breath control
Registration Number
NCT01285193
Lead Sponsor
Penang Hospital, Malaysia
Brief Summary

The purpose of this study is to determine if blood pressure can be reduced in hypertensive subjects by regularising and slowing their breathing. This may be a safe and affordable complementary treatment for hypertension.

Detailed Description

This is a randomised controlled trial in which hypertensive subjects allocated to receive either a CD with relaxation music or one with the same music plus certain sound cues to guide the listener on when to breathe. The subjects will continue with their normal medications and the intervention will last 2 months.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
84
Inclusion Criteria
  • Above 18 years old
  • Patients with essential hypertension
  • Systolic BP from 140 to 159 mm Hg
  • Diastolic BP from 90 to 99 mm Hg
  • On hypertensive medication for at least 3 months before the study
  • Hypertensive medication unchanged during the 3 months before the study
  • Patients able to fill in a log sheet
Exclusion Criteria
  • ischaemic heart disease
  • congestive heart failure
  • cardiac arrhythmias
  • renal failure
  • diabetes mellitus
  • previous stroke
  • major organ failure
  • cigarette smoking
  • respiratory diseases
  • psychiatric disorders
  • severe obesity (BMI >35 kg/m2)
  • hearing impairment
  • unable to operate a CD player or do not have access to a CD player
  • arm circumference <22 cm. or >42 cm.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Breath controlBreath controlA music CD with sound cues is used to guide the subject to breathe in a regular and slower rate. This is practiced for at least 15 minutes a day over 2 months.
Primary Outcome Measures
NameTimeMethod
Diastolic blood pressure2 months

Change in diastolic blood pressure from baseline to end value at 2 months.

Secondary Outcome Measures
NameTimeMethod
Systolic blood presure2 months

Change in systolic blood pressure from baseline to end value at 2 months.

Trial Locations

Locations (1)

Ng Kum Keong

🇲🇾

Georgetown, Penang, Malaysia

© Copyright 2025. All Rights Reserved by MedPath